Click Here To View
Latest Blood Sugar Articles
Popular Blood Sugar Articles
Highly Recommended Blood Sugar Articles
Send a link to this page to your friends and colleagues.
With 21 million U.S. residents now officially diagnosed as having diabetes, healthcare professionals are looking at another statistic that is causing them many a sleepless night: The Centers for Disease Control estimate that there are 57 million people with pre-diabetes in the United States. (Pre-diabetes is defined as impaired fasting glucose of 100 to 125 mg/dl, impaired glucose tolerance of 140 to 199 mg/dl, or both.)
According to an American College of Endocrinology (ACE) task force, about 6 to 10 percent of patients with impaired glucose tolerance develop diabetes each year, while 60 percent of patients who have both impaired fasting glucose and glucose tolerance develop diabetes within six years.
In response to these statistics, healthcare providers are starting to reach a consensus: Treating pre-diabetes should be a pull-out-all-the-stops effort that rivals the aggressiveness with which they currently treat newly diagnosed cases of diabetes.
The five main elements of this assertive approach to pre-diabetes include:
The first two elements are a significant departure from current standard treatment. Most doctors have relied in the past on fasting tests for glucose, but have come to realize that many patients do not fast correctly or are subject to blood glucose spikes that a one-time test simply can't reveal. Because the A1c gives a reading over a 90- to 120-day period, it is a far more accurate diagnostic tool.
Many doctors have prescribed metformin to non-diabetic patients to assist with liver function or to address high glucose levels caused by other factors. The addition of acarbose (manufactured by Bayer and called "Precose" in the United States and "Glucobay" in Europe) slows the absorption of sugars and starches into the system and also suppresses appetite. Together, these drugs provide a one-two punch against high BG levels by lowering the amount of glucose the body produces as well as the speed with which it absorbs it.
The recommendation that people with pre-diabetes meet the same blood pressure and lipid level goals as diabetics means that doctors may soon begin prescribing cholesterol and blood pressure control drugs without waiting for a diagnosis of diabetes.
These more aggressive approaches are intended to delay-perhaps even totally prevent-the onset of diabetes. Given the many harmful and costly side effects that come with diabetes, healthcare professionals are coming to believe that several pounds of prevention are worth a ton of cure.